These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 36724861

  • 21. Ataxin-1 regulates proliferation of hippocampal neural precursors.
    Asher M, Johnson A, Zecevic B, Pease D, Cvetanovic M.
    Neuroscience; 2016 May 13; 322():54-65. PubMed ID: 26876606
    [Abstract] [Full Text] [Related]

  • 22. Cerebellar Heterogeneity and Selective vulnerability in Spinocerebellar Ataxia Type 1 (SCA1).
    Hamel K, Moncada EL, Sheeler C, Rosa JG, Gilliat S, Zhang Y, Cvetanovic M.
    Neurobiol Dis; 2024 Jul 13; 197():106530. PubMed ID: 38750673
    [Abstract] [Full Text] [Related]

  • 23. ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.
    Rousseaux MWC, Tschumperlin T, Lu HC, Lackey EP, Bondar VV, Wan YW, Tan Q, Adamski CJ, Friedrich J, Twaroski K, Chen W, Tolar J, Henzler C, Sharma A, Bajić A, Lin T, Duvick L, Liu Z, Sillitoe RV, Zoghbi HY, Orr HT.
    Neuron; 2018 Mar 21; 97(6):1235-1243.e5. PubMed ID: 29526553
    [Abstract] [Full Text] [Related]

  • 24. Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.
    Ingram M, Wozniak EAL, Duvick L, Yang R, Bergmann P, Carson R, O'Callaghan B, Zoghbi HY, Henzler C, Orr HT.
    Neuron; 2016 Mar 16; 89(6):1194-1207. PubMed ID: 26948890
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic Strategies for Spinocerebellar Ataxia Type 1.
    Kerkhof LMC, van de Warrenburg BPC, van Roon-Mom WMC, Buijsen RAM.
    Biomolecules; 2023 May 02; 13(5):. PubMed ID: 37238658
    [Abstract] [Full Text] [Related]

  • 26. Partial loss of ataxin-1 function contributes to transcriptional dysregulation in spinocerebellar ataxia type 1 pathogenesis.
    Crespo-Barreto J, Fryer JD, Shaw CA, Orr HT, Zoghbi HY.
    PLoS Genet; 2010 Jul 08; 6(7):e1001021. PubMed ID: 20628574
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model.
    Watase K, Gatchel JR, Sun Y, Emamian E, Atkinson R, Richman R, Mizusawa H, Orr HT, Shaw C, Zoghbi HY.
    PLoS Med; 2007 May 08; 4(5):e182. PubMed ID: 17535104
    [Abstract] [Full Text] [Related]

  • 32. Differential effects of Wnt-β-catenin signaling in Purkinje cells and Bergmann glia in spinocerebellar ataxia type 1.
    Luttik K, Tejwani L, Ju H, Driessen T, Smeets CJLM, Edamakanti CR, Khan A, Yun J, Opal P, Lim J.
    Proc Natl Acad Sci U S A; 2022 Aug 23; 119(34):e2208513119. PubMed ID: 35969780
    [Abstract] [Full Text] [Related]

  • 33. BIIB021, a synthetic Hsp90 inhibitor, induces mutant ataxin-1 degradation through the activation of heat shock factor 1.
    Ding Y, Adachi H, Katsuno M, Sahashi K, Kondo N, Iida M, Tohnai G, Nakatsuji H, Sobue G.
    Neuroscience; 2016 Jul 07; 327():20-31. PubMed ID: 27058144
    [Abstract] [Full Text] [Related]

  • 34. Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1.
    Chopra R, Bushart DD, Cooper JP, Yellajoshyula D, Morrison LM, Huang H, Handler HP, Man LJ, Dansithong W, Scoles DR, Pulst SM, Orr HT, Shakkottai VG.
    Hum Mol Genet; 2020 Nov 25; 29(19):3249-3265. PubMed ID: 32964235
    [Abstract] [Full Text] [Related]

  • 35. Mood alterations in mouse models of Spinocerebellar Ataxia type 1.
    Asher M, Rosa JG, Cvetanovic M.
    Sci Rep; 2021 Jan 12; 11(1):713. PubMed ID: 33436887
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Purkinje cell COX deficiency and mtDNA depletion in an animal model of spinocerebellar ataxia type 1.
    Ripolone M, Lucchini V, Ronchi D, Fagiolari G, Bordoni A, Fortunato F, Mondello S, Bonato S, Meregalli M, Torrente Y, Corti S, Comi GP, Moggio M, Sciacco M.
    J Neurosci Res; 2018 Sep 12; 96(9):1576-1585. PubMed ID: 30113722
    [Abstract] [Full Text] [Related]

  • 39. Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model.
    Hearst SM, Shao Q, Lopez M, Raucher D, Vig PJ.
    Cerebellum; 2014 Oct 12; 13(5):596-606. PubMed ID: 24930030
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.